Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts.
about
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancerProgrammed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta roleFragment Length of Circulating Tumor DNAMulti-purpose utility of circulating plasma DNA testing in patients with advanced cancersOrigins, structures, and functions of circulating DNA in oncologyNoninvasive saliva-based EGFR gene mutation detection in patients with lung cancer.Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferasesAssociation Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.High fragmentation characterizes tumour-derived circulating DNA.Liquid biopsy: monitoring cancer-genetics in the blood.Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib.Circulating tumour markers can define patients with normal colons, benign polyps, and cancers.Circulating tumor-derived DNA is shorter than somatic DNA in plasma.Diagnostic Performance of Plasma DNA Methylation Profiles in Lung Cancer, Pulmonary Fibrosis and COPD.Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients.Cell-Free DNA Provides a Good Representation of the Tumor Genome Despite Its Biased Fragmentation Patterns.Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA.Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats.Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?Molecular characterization of patient-derived human pancreatic tumor xenograft models for preclinical and translational development of cancer therapeuticsAnalysis of tumor template from multiple compartments in a blood sample provides complementary access to peripheral tumor biomarkersConcentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer.Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients.Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancer.Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistanceNeutrophil extracellular traps: a walk on the wild side of exercise immunology.Tumor circulating DNA profiling in xenografted mice exposed to intermittent hypoxia.Circulating DNA Demonstrates Convergent Evolution and Common Resistance Mechanisms during Treatment of Colorectal Cancer.Clinical Applications of Liquid Biopsies in Gastrointestinal Oncology.Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer.The liquid biopsy in lung cancerLiquid biopsies come of age: towards implementation of circulating tumour DNA.Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA.DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer.Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancerEpigenetic alteration: new insights moving from tissue to plasma - the example of PCDH10 promoter methylation in colorectal cancer.Further the liquid biopsy: Gathering pieces of the puzzle of genometastasis theory.
P2860
Q26746010-D054BB36-9AD6-4A7D-927D-C943EAB22891Q26769734-E61D9BBD-B42F-4BBD-9F75-9D03186758B9Q27308628-5ABCE6B5-8DAF-4308-9BBE-8475D33BC413Q28484970-59002F53-6362-455F-B91D-3C4FFBB09F17Q30249103-9E561CFA-4D7E-4C82-9AEC-E7512F32F448Q33735738-77B495F0-35D5-4ED2-A335-D498B004917CQ33764406-45D95049-E316-4045-9950-3607FBF59DDCQ33911932-9D394487-BFCE-42C8-A671-5ED2654C8BD0Q34016528-7043A99A-CF8D-45CA-9E14-D34D41440565Q34356149-04E42B14-B940-46BE-933C-E0F4D5FB9213Q35095761-070FAC36-A858-40A3-8C02-829C6DB34598Q35125657-69FC650E-5F0B-439A-BE1D-801E881DBC78Q35212453-4B5BC59F-CD3D-457F-9DC2-2DB264E7932DQ36038684-8F57FC4B-CF46-4D3C-A2A2-47180A3DACDCQ36104839-9A569E11-416D-47AE-B910-E5249D061BB2Q36238197-282E65B4-9F2E-4308-806B-9B742A6ADD7FQ36318273-C61715E4-66BE-4716-83C5-12B0AE049FB1Q36597182-83F9BF10-4D5C-4236-8359-44E849FE729AQ36865058-C84BDA7D-54AD-4665-BEA2-D992FE4131A4Q37242412-2363D33E-E57D-4B38-9250-EE7E4AC5CCD1Q37285542-FFFBE524-7C1E-4101-9252-8D8500313F16Q37295773-0B948894-26F3-4E92-813E-19FB22026347Q37306747-67872068-39F5-4FDF-A97E-1B0C895A8843Q37641638-7806099E-31A1-4396-8EDC-03858C5B26EDQ38010746-44A06B72-F70D-4A98-B74D-5364D29C10F1Q38203956-BB7438D3-EC77-4B7B-8DFE-B10774C9CE8DQ38216129-A4088B83-64D7-427A-B409-41C535AF4A87Q38249332-DC9E72A2-F9E8-43FD-AB5F-D204F624AC35Q38287683-D7BB558A-F4D6-453D-8528-F0E0060B4ED4Q38302944-58E8D376-15CE-4A8F-A0A6-66771A4D2543Q38375059-192B530E-E95A-44BB-AD86-F7C821094145Q38800475-3CE303E9-7542-45BC-B05A-E7C17F038EE4Q39051797-A8B43DFE-7981-464C-BFCD-845C46F03B9CQ39132753-67AAF5E4-479C-4750-9CBD-F6F671134A11Q39149201-A584BB31-9E6E-428D-A5EF-1DC46D0767A8Q39344296-F0205F29-DD8C-4EA7-9343-9C2A8813A897Q40848507-FFEF66F6-EEA1-44FB-9D23-802D10A99CC4Q41134871-92AF883D-C2B7-4BFF-8851-7AA57B6D19B1Q42546251-2DAB3AA4-FE60-40EB-9A8B-C3A7007AA887Q42702940-D556F092-0A17-4794-A858-A353D2EA4F94
P2860
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Origin and quantification of c ...... colorectal cancer xenografts.
@ast
Origin and quantification of c ...... colorectal cancer xenografts.
@en
Origin and quantification of c ...... colorectal cancer xenografts.
@nl
type
label
Origin and quantification of c ...... colorectal cancer xenografts.
@ast
Origin and quantification of c ...... colorectal cancer xenografts.
@en
Origin and quantification of c ...... colorectal cancer xenografts.
@nl
prefLabel
Origin and quantification of c ...... colorectal cancer xenografts.
@ast
Origin and quantification of c ...... colorectal cancer xenografts.
@en
Origin and quantification of c ...... colorectal cancer xenografts.
@nl
P2093
P2860
P356
P1476
Origin and quantification of c ...... colorectal cancer xenografts.
@en
P2093
Alain R Thierry
Bruno Robert
Celine Gongora
Florent Mouliere
Franck Molina
Jeremy Ollier
Maguy Del Rio
Marc Ychou
P2860
P304
P356
10.1093/NAR/GKQ421
P407
P577
2010-05-21T00:00:00Z